Hospital facility prices. What the hospital charges for the
facility side of care — the surgeon’s and anesthesiologist’s
fees are billed separately and are not included.
How we scope prices →
HANK Price Transparency. (n.d.).
RITUXIMAB-HYALURONIDASE HUMAN 1600-26800 MG -UT/13.4ML SC SOLN (NDC 50242010901) by Hospital.
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved , from http://ppman.hank.ai/transparency/procedure/50242010901/by-hospital?code_type=NDC
MLA (9th ed.)
“RITUXIMAB-HYALURONIDASE HUMAN 1600-26800 MG -UT/13.4ML SC SOLN (NDC 50242010901) by Hospital.” HANK Price Transparency,
http://ppman.hank.ai/transparency/procedure/50242010901/by-hospital?code_type=NDC. Accessed
.
Chicago (notes-bibliography)
“RITUXIMAB-HYALURONIDASE HUMAN 1600-26800 MG -UT/13.4ML SC SOLN (NDC 50242010901) by Hospital,” HANK Price Transparency,
accessed ,
http://ppman.hank.ai/transparency/procedure/50242010901/by-hospital?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology.
NDC · across hospitals
50242010901 — Rituximab-hyaluronidase Human 1600-26800 Mg -ut/13.4ml Sc Soln
Hospital-by-hospital median negotiated rates.
Hospitals are ranked by their typical (median) negotiated rate (highest first by default; click a column to re-sort). Outliers are flagged
where a hospital's median is more than 2× or less than 0.5× the
cohort median (red = high, green = low).